Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion type Assertion NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_head.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion wasGeneratedBy ECO_0000203 NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_provenance.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion wasDerivedFrom befree-20150227 NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_provenance.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion SIO_000772 24588013 NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_provenance.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion evidence source_evidence_literature NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_provenance.
- NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_assertion description "[Drug targeting of fusion genes has proven to be an extremely effective therapeutic approach for cancers such as the recurrent BCR–ABL1 fusion in chronic myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265531.RAssW392FROqQ3BjGhg5BwQL263pCj2ll3Ai11u_jNnrI130_provenance.